Ku70 is essential for histone deacetylase inhibitor trichostatin A-induced apoptosis

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 581-586

  Meng, Jin ^a,b   Zhang, Feng ^a   Zhang, Xu Tao ^a   Zhang, Tao ^c   Li, Yu Hua ^a   Fan, Lei ^a   Sun, Yang ^a   Zhang, He Long ^c   Mei, Qi Bing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b 309TH HOSPITAL OF PLA   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; B cell lymphoma 2 associated X protein; Colorectal cancer cells; Ku70; Trichostatin A

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CYTOCHROME C; KU ANTIGEN; PROTEIN BAX; SMALL INTERFERING RNA; TRICHOSTATIN A; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CELL NUCLEUS ANTIGEN; DNA BINDING PROTEIN; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; LEUPEPTIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HCT116 CELL LINE; HT 29 CELL LINE; HUMAN; HUMAN CELL; MITOCHONDRION; PROTEIN ACETYLATION; PROTEIN EXPRESSION; PROTEIN SECRETION; ACETYLATION; BIOSYNTHESIS; COLORECTAL TUMOR; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ACETYLATION; ANTIGENS, NUCLEAR; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; COLORECTAL NEOPLASMS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HISTONE DEACETYLASE INHIBITORS; HT29 CELLS; HUMANS; HYDROXAMIC ACIDS; LEUPEPTINS;

EID: 84926651866     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3358     Document Type: Article

References (23)

1. Jernal A, Siegel R, Ward E, et al: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Johnstone RW: Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 1: 287-299, 2002.
3. Yu X, Guo ZS, Marcu MG, et al: Modulation of p53, ErbB1, ErbB2 and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J Natl Cancer Inst 94: 504-513, 2002.
4. Zhu WG and Otterson GA: The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells. Curr Med Chem Anti-Cancer Agents 3: 187-199, 2003.
5. Meinke PT and Liberator P: Histone deacetylase: a target for antiproliferative and antiprotozoal agents. Curr Med Chem 8: 211-235, 2001.
6. Yoshida M, Kijima M, Akita M and Beppu T: Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265: 17174-17179, 1990.
7. Meng J, Zhang HH, Zhou CX, Li C, Zhang F and Mei QB: The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. Oncol Rep 28: 384-388, 2012.
8. Sawada M, Sun W, Hayes P, Leskov K, Boothman DA and Matsuyama S: Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 5: 320-329, 2003.
9. Cohen HY, Lavu S, Bitterman KJ, et al: Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell 13: 627-638, 2004.
10. Zhang F, Bäumer N, Rode M, et al: The inhibitor of growth protein 5 (ING5) depends on INCA1 as a co-factor for its antiproliferative effects. PLoS One 6: e21505, 2011.
11. Kroemer G: Mitochondrial implication in apoptosis: towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Differ 4: 443-456, 1997.
12. Reed JC: Cytochrome c: can't live with it-can't live without it. Cell 91: 559-562, 1997.
13. Lindemann RK, Gabrielli B and Johnstone RW: Histone-deacetylase inhibitors for the treatment of cancer. Cell Cycle 3: 779-788, 2004.
14. De Giorgi F, Lartigue L, Bauer MK, et al: The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J 16: 607-609, 2002.
15. Subramanian C, Hada M, Opipari AW Jr, Castle VP and Kwok RP: CREB-binding protein regulates Ku70 acetylation in response to ionization radiation in neuroblastoma. Mol Cancer Res 11: 173-181, 2013.
16. Collis SJ, DeWeese TL, Jeggo PA, et al: The life and death of DNA-PK. Oncogene 24: 949-961, 2005.
17. He F, Li L, Kim D, et al: Adenovirus-mediated expression of a dominant negative Ku70 fragment radiosensitizes human tumor cells under aerobic and hypoxic conditions. Cancer Res 67: 634-642, 2007.
18. Shintani S, Mihara M, Li C, et al: Up-regulation of DNA- dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Sci 94: 894-900, 2003.
19. Hashimoto M, Rao S, Tokuno O, et al: DNA-PK: the major target for wortmannin-mediated radiosensitization by the inhibition of DSB repair via NHEJ pathway. J Radiat Res 44: 151-159, 2003.
20. Com E, Lagadec C, Page A, et al: Nerve growth factor receptor TrkA signaling in breast cancer cells involves Ku70 to prevent apoptosis. Mol Cell Proteomics 6: 1842-1854, 2007.
21. Lee JC, Lee CH, Su CL, et al: Justicidin A decreases the level of cytosolic Ku70 leading toapoptosis in human colorectal cancer cells. Carcinogenesis 26: 1716-1730, 2005.
22. Koike M, Yutoku Y and Koike A: The defect of Ku70 affects sensitivity to x-ray and radiation-induced caspase-dependent apoptosis in lung cells. J Vet Med Sci 75: 415-420, 2013.
23. Amsel AD, Rathaus M, Kronman N and Cohen HY: Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation. Cell Biol 105: 5117-5122, 2008.